BACKGROUND: Persistence of seroprotective bactericidal antibody titers is important for long-term protection against meningococcal serogroup C disease in young children. Antibody persistence values were determined in children up to 3 years after vaccination with a single dose of the combined Haemophilus influenzae type b (Hib)–Neisseria meningitidis serogroup C (MenC)-tetanus toxoid (TT) conjugate vaccine (Hib-MenC-TT; www.ClinicalTrials.gov: NCT00326118). METHODS: The children had been randomized at ages 12–18 months to receive either 1 dose of Hib-MenC-TT (Hib-MenC group) or separately administered Hib-TT conjugate vaccine and MenC-CRM197 (MCC) vaccine (Hib plus MCC group). All children had been primed in infancy with a Hib vaccine. Antib...
The kinetics of antibody persistence following the administration of a combination meningococcal ser...
Background: The multicomponent serogroup B meningococcal (4CMenB) vaccine was recently licensed for ...
BACKGROUND: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
Background: Antibody persistence is evaluated in healthy Australian children 4 and 5 years postvacci...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are a...
BACKGROUND:We assessed immunogenicity, antibody persistence and safety of the meningococcal serogrou...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are a...
BACKGROUND:One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are ad...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
Background: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
Hib-primed but MenC-naive toddlers (N = 433) were randomized to receive 1 dose of Hib-MenC-TT or sep...
This phase 3B, open-label, extension study (NCT01962207) evaluated long-term persistence of antibodi...
The kinetics of antibody persistence following the administration of a combination meningococcal ser...
Background: The multicomponent serogroup B meningococcal (4CMenB) vaccine was recently licensed for ...
BACKGROUND: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
Background: Antibody persistence is evaluated in healthy Australian children 4 and 5 years postvacci...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are a...
BACKGROUND:We assessed immunogenicity, antibody persistence and safety of the meningococcal serogrou...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
BACKGROUND: One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are a...
BACKGROUND:One schedule for the capsular group B meningococcal vaccine 4CMenB is 2 doses that are ad...
BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningi...
Background: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...
Hib-primed but MenC-naive toddlers (N = 433) were randomized to receive 1 dose of Hib-MenC-TT or sep...
This phase 3B, open-label, extension study (NCT01962207) evaluated long-term persistence of antibodi...
The kinetics of antibody persistence following the administration of a combination meningococcal ser...
Background: The multicomponent serogroup B meningococcal (4CMenB) vaccine was recently licensed for ...
BACKGROUND: After immunization with serogroup C meningococcal (MenC) conjugate vaccine, antibody res...